GENE ONLINE|News &
Is Exosome the Next Rising Star?
The exosome diagnostics and therapeutics market was valued at US$ 46 million in 2019 and is expected to reach US$ 617 million by 2027 with a CAGR of 38%. The global growth mainly results from the rising prevalence of chronic diseases and incidence of cancer.
Currently, there are still some challenges ahead that need to overcome in the future. This includes the validation and standardization for the exosome and the heavy investment in manufacturing, research, and development activities.
Currently, there are still some challenges ahead that need to overcome in the future. This includes the validation and standardization for the exosome and the heavy investment in manufacturing, research, and development activities.
GO Prime with only $1.49 now
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
